Pemphigoid nodularis triggered by hypereosinophilic syndrome?;Pemphigoid nodularis ausgehend von einem Hypereosinophilie-Syndrom?

Hautarzt

Volumn 57, Issue 5, 2006, Pages 434-436

  Von Felbert, V ^a   Simon, D ^b   Braathen, L ^b   Hunziker, T ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Autoantibodies; Hypereosinophilic dermatitis; Hypereosinophilic syndrome; Pemphigoid nodularis

Indexed keywords

ANTIHISTAMINIC AGENT; AUTOANTIBODY; AZATHIOPRINE; DAPSONE; DOXEPIN; HYDROXYUREA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ARTICLE; BLISTER; CASE REPORT; DERMATITIS; ECZEMA; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; HYPEREOSINOPHILIC SYNDROME; OBSTRUCTIVE AIRWAY DISEASE; PEMPHIGOID; PEMPHIGOID NODULARIS; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRURIGO; URTICARIA;

AGED; FEMALE; HUMANS; HYPEREOSINOPHILIC SYNDROME; PEMPHIGOID, BULLOUS;

EID: 33646570200     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-005-0940-7     Document Type: Article

References (5)

1. Borrego L, Maynard B, Peterson EA et al. (1996) Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Am J Pathol 148: 897-909
2. Braun B, Baima B, Sticherling M (2002) Bullous pemphigoid manifesting as dyshidrotic eczema and prurigo nodularis. Hautarzt 53: 739-743
3. Nir MA, Westfried M (1981) Hypereosinophilic dermatitis. A distinct manifestation of the hypereosinophilic syndrome with response to dapsone. Dermatologica 162: 444-450
4. Plotz SG, Simon HU, Darsow U et al. (2003) Use of an anti-IL-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 349: 2334-2339
5. Powell AM, Albert S, Gratian MJ, Bittencourt R, Bhogal BS, Black MM (2002) Pemphigoid nodularis (non-bullous): a clinicopathological study of five cases. Br J Dermatol 147: 343-349